Targeting the tumour's Achilles heel: ATR inhibition to exploit a constitutive vulnerability of hepatoblastoma

Nina Desboeufs1, Achim Weber1

  • 1Department of Pathology and Molecular Pathology, University of Zurich (UZH) and University Hospital Zurich (USZ), Zurich, Switzerland; Institute of Molecular Cancer Research, University of Zurich (UZH), Zurich, Switzerland.

Journal of Hepatology
|February 13, 2026
PubMed
Abstract

No abstract available in PubMed .